Stanford Medicine Corporate Partners Program
The impact of the Corporate Partners program will be profound. Stanford Health Care, Lucile Packard Children’s Hospital Stanford and the Stanford School of Medicine are joining with the pioneering leaders of Silicon Valley to deliver a new standard of proactive, predictive medicine to patients of all ages.
President and CEO of Stanford Health Care
Established in 2011, the Stanford Medicine Corporate Partners Program is a philanthropic engagement between Stanford Medicine and leading global companies to inspire and create solutions to improve patient care and promote lifelong health on a global scale.
Stanford Medicine Corporate Partners include Adobe, Apple, Cisco, eBay, HP, Hewlett Packard Enterprise, Intel, Intuit, NVIDIA, Oracle, Paypal, and VMware.
Together, we are transforming the very concept of medicine—from preventing and predicting disease, successfully treating it after it has struck, and promoting lifelong health.
Executive Director Corporate Health Care Programs
Stanford Health Care
In addition to the Stanford Medicine Corporate Partners Program, there are a number of ways in which companies can leverage their resources through a relationship with Stanford Medicine.
Support faculty, students, or facilities through a broad partnership
By making gifts to Stanford Medicine, corporations strengthen their relationship with one of the world's leading research universities, support departments and faculty engaged in research related to their interests, honor individuals who have played key roles in their success, introduce their companies and their products to future users, and support and encourage the philanthropy of their employees. For more information, contact Joy Morimoto, Director of Corporate and Foundation Relations, at 650.736.9749 or firstname.lastname@example.org.
License specific technology
As a major research university, Stanford receives a significant portion of its funding from organizations that sponsor research by financially underwriting projects at Stanford. Usually awarded upon submission and evaluation of a proposal, sponsored projects typically include a statement of work, a budget, and terms for the disposition of resulting tangible and intangible property.
Sponsor clinical trials
Clinical trials are ongoing at Stanford Medicine involving pharmaceutical, biotechnology, and medical device therapeutics. The clinical faculty participate in Phase I, II, and III clinical trials, as well as industry-sponsored preclinical research and human subjects studies for new indications for approved drugs (Phase IV). Many clinical trials are part of a multi-center format, and Stanford has served as the organizing site for some of these trials. For more information, contact:
- Non-cancer studies:
Linda Walker, Program Manager, Spectrum, at email@example.com or 650.498.6498
- For cancer-related trials:
The Cancer Clinical Trials Office (CCTO) at firstname.lastname@example.org or 650.724.0153.